Maria Stamelou, MD, PhD
Assistant Professor of Neurology, University of Marburg, Germany
Head of Movement Disorders Department, “HYGEIA” Hospital, Athens, Greece
Collaborating consultant and reasearhcer at University of Athens Medical School, 2nd Department of Neurology, Hospital “Attikon”, Athens, Greece
Leonidas Stefanis, MD, PhD
Professor of Neurology and Neurobiology
University of Athens Medical School
Director, 2nd Department of Neurology
Hospital “Attikon”, Athens, Greece
Director of Laboratory of Neurodegenerative Diseases
Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Greece
tel: 30-210-6597214 or 30-210-6597498
In the Second Department of Neurology, of the National and Kapodistrian University of Athens, at the Attikon Hospital we have a specialized Movement Disorders clinic which currently counts over 700 patients with parkinsonian syndromes. The hospital has a nuclear medicine department and performs DaTSCANs and MIBG- SPECT since over a decade now. We have access to 3T-MRI and FDG-PET. We also have a sleep-centre (Dr Tasos Bonakis), which counts more than 50 patients with idiopathic RBD and performs regular PSGs in parkinsonian patients. In terms of basic science, we are collaborating with the Biomedical Research Foundation (BRFAA) of the Academy of Athens where, apart from other research activities mostly related to a-syn, using cellular and animal models, we are also storing and processing biological samples from our patients.
Stamelou M, Bhatia KP. Atypical parkinsonism - new advances. Curr Opin Neurol 2016;29:480-485.
Mylius V, Pee S, Pape H, Teepker M, Stamelou M, Eggert K, Lefaucheur JP, Oertel WH, Moller JC. Experimental pain sensitivity in multiple system atrophy and Parkinson's disease at an early stage. Eur J Pain 2016;20:1223-1228.
Kim HJ, Stamelou M, Jeon B. Multiple system atrophy-mimicking conditions: Diagnostic challenges. Parkinsonism Relat Disord 2016;22 Suppl 1:S12-15.
Huppertz HJ, Moller L, Sudmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Respondek G, Stamelou M, Schnitzler A, Pinkhardt EH, Oertel WH, Knake S, Kassubek J, Hoglinger GU. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord 2016.
Stamelou M, Pilatus U, Reuss A, Respondek G, Knake S, Oertel WH, Hoglinger GU. Brain energy metabolism in early MSA-P: A phosphorus and proton magnetic resonance spectroscopy study. Parkinsonism Relat Disord 2015;21:533-535.
Stamelou M, Diehl-Schmid J, Hapfelmeier A, Kontaxopoulou D, Stefanis L, Oertel WH, Bhatia KP, Papageorgiou SG, Hoglinger GU. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias. Parkinsonism Relat Disord 2015;21:1264-1268.
Stamelou M, Bhatia KP. Atypical parkinsonism: diagnosis and treatment. Neurol Clin 2015;33:39-56.
Respondek G, Stamelou M, Movement Disorder Society-endorsed PSP Study Group. et al; The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord. 2014 Dec;29(14):1758-66.
Stamelou M, Quinn NP, Bhatia KP. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide. Mov Disord 2013;28:1184-1199.
Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP. Markedly asymmetric presentation in multiple system atrophy. Parkinsonism Relat Disord 2013;19:901-905.
Winter Y, Stamelou M, Cabanel N, Sixel-Doring F, Eggert K, Hoglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. J Neurol 2011;258:1827-1834.
Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Hoglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 2011;8:438-446.
Stamelou M, Christ H, Reuss A, Oertel W, Hoglinger G. Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes. Mov Disord 2011;26:901-905.